These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 333255)

  • 1. [Pathobiochemistry of porphyrias].
    Doss M
    Med Klin; 1977 Sep; 72(38):1501-18. PubMed ID: 333255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of determination of porphyrins and their precursors for the evaluation of disorders of heme synthesis in the liver after exposure to xenobiotics].
    Stankiewicz A; Lutz W
    Postepy Hig Med Dosw; 1988; 42(5):574-88. PubMed ID: 3076238
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatic porphyrias.
    Romeo G
    Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654
    [No Abstract]   [Full Text] [Related]  

  • 5. The laboratory investigation of the porphyrin disorders: a review.
    Sinnott JL
    Med Lab Sci; 1976 Apr; 33(2):133-53. PubMed ID: 781455
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyric diseases in man.
    Levere RD; Pindyck J
    Ann Clin Lab Sci (1971); 1971; 1(2):101-12. PubMed ID: 4949571
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic porphyrias: new findings on the nature of metabolic defects.
    Meyer UA
    Prog Liver Dis; 1976; 5():280-93. PubMed ID: 775544
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs and the hepatic porphyrias.
    Smith AG; De Matteis F
    Clin Haematol; 1980 Jun; 9(2):399-425. PubMed ID: 7398153
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute intermittent porphyria--a clinical review].
    Lithner F
    Lakartidningen; 1979 Dec; 76(52):4798-4801. PubMed ID: 545005
    [No Abstract]   [Full Text] [Related]  

  • 10. Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
    Doss M; Schermuly E; Koss G
    Ann Clin Res; 1976; 8 Suppl 17():171-81. PubMed ID: 1008488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic porphyrias: pathogenesis, manifestations, and management.
    Bloomer JR
    Gastroenterology; 1976 Oct; 71(4):689-701. PubMed ID: 955357
    [No Abstract]   [Full Text] [Related]  

  • 12. Heme synthesis in protoporphyria.
    Bloomer JR; Hill HD; Kools AM; Straka JG
    Curr Probl Dermatol; 1991; 20():135-47. PubMed ID: 1935205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nephrologists and porphyrias].
    Canavese C; Gabrielli D; Guida C; Cappellini MD
    G Ital Nefrol; 2002; 19(4):393-412. PubMed ID: 12369042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic porphyrias].
    Crispin M; Szeinberg A
    Harefuah; 1972 Feb; 82(3):137-9. PubMed ID: 4565661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reversibility of griseofulvin induced protoporphyria in the mice].
    Irifune H
    Nihon Hifuka Gakkai Zasshi; 1987 Jun; 97(7):801-4. PubMed ID: 3669397
    [No Abstract]   [Full Text] [Related]  

  • 16. Anesthesia and the porphyrias.
    Mees DE; Frederickson EL
    South Med J; 1975 Jan; 68(1):29-32. PubMed ID: 1154054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal erythrohepatic protoporphyria.
    Zawirska B; Richter R; Harłozińska A; Szechiński J; Skoczyńska A
    Patol Pol; 1986; 37(1):74-81. PubMed ID: 3822551
    [No Abstract]   [Full Text] [Related]  

  • 18. The porphyrias--a review.
    Waldenström J
    Haematologia (Budap); 1981; 14(3):231-45. PubMed ID: 7035307
    [No Abstract]   [Full Text] [Related]  

  • 19. The biochemical basis of the acute porphyrias.
    McColl KE; Goldberg A
    Biochem Soc Trans; 1983 Dec; 11(6):631-2. PubMed ID: 6336314
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.
    Abbritti G; De Matteis F
    Chem Biol Interact; 1972 Mar; 4(4):281-6. PubMed ID: 5008942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.